Vertebral fractures after denosumab cessation

Cleve Clin J Med. 2020 Jun;87(6):337-338. doi: 10.3949/ccjm.87a.19152.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Back Pain* / diagnosis
  • Back Pain* / etiology
  • Bone Density Conservation Agents / adverse effects
  • Bone Density Conservation Agents / therapeutic use
  • Bone Remodeling / drug effects
  • Denosumab / therapeutic use*
  • Diagnosis, Differential
  • Drug Substitution / methods
  • Female
  • Humans
  • Lumbar Vertebrae* / diagnostic imaging
  • Lumbar Vertebrae* / injuries
  • Middle Aged
  • Osteoporosis, Postmenopausal* / drug therapy
  • Osteoporosis, Postmenopausal* / metabolism
  • Risk Adjustment / methods
  • Secondary Prevention / methods
  • Spinal Fractures* / diagnosis
  • Spinal Fractures* / etiology
  • Thoracic Vertebrae* / diagnostic imaging
  • Thoracic Vertebrae* / injuries
  • Withholding Treatment / standards*
  • Zoledronic Acid / administration & dosage

Substances

  • Bone Density Conservation Agents
  • Denosumab
  • Zoledronic Acid